Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Net Margin (2021 - 2024)

Solid Biosciences' Net Margin history spans 4 years, with the latest figure at 50728.0% for Q4 2024.

  • For Q4 2024, Net Margin changed N/A year-over-year to 50728.0%; the TTM value through Dec 2024 reached 35470.29%, down 638746.0%, while the annual FY2024 figure was 35470.29%, N/A changed from the prior year.
  • Net Margin for Q4 2024 was 50728.0% at Solid Biosciences, up from 40165.85% in the prior quarter.
  • Across five years, Net Margin topped out at 50728.0% in Q4 2024 and bottomed at 1315.22% in Q1 2022.
  • The 4-year median for Net Margin is 11417.57% (2022), against an average of 15825.2%.
  • The largest annual shift saw Net Margin plummeted -80847bps in 2022 before it skyrocketed 2639952bps in 2023.
  • A 4-year view of Net Margin shows it stood at 509.78% in 2021, then skyrocketed by 180bps to 408.1% in 2022, then surged by 5395bps to 22427.03% in 2023, then soared by 126bps to 50728.0% in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Net Margin are 50728.0% (Q4 2024), 40165.85% (Q3 2024), and 28762.5% (Q2 2024).